AI Article Synopsis

  • - A study analyzed COVID-19 vaccine effectiveness among 521,206 emergency department visits and 139,548 hospitalizations between June 2021 and September 2022, focusing on adults with disabilities.
  • - Of the encounters, only 2% had documented disabilities, but those individuals represent a significant portion of hospitalizations (12%).
  • - The results showed that COVID-19 vaccines worked similarly for both disabled and non-disabled adults, highlighting the need for disabled individuals to keep their vaccinations current to protect against severe disease.

Article Abstract

Adults with disabilities are at increased risk for severe coronavirus disease 2019 (COVID-19). Using data across 9 states during Delta- and Omicron-predominant periods (June 2021-September 2022), we evaluated the effectiveness of the original monovalent COVID-19 messenger RNA vaccines among 521 206 emergency department/urgent care encounters (11 471 [2%] in patients with a documented disability) and 139 548 hospitalizations (16 569 [12%] in patients with a disability) for laboratory-confirmed COVID-19 illness in adults (aged ≥18 years). Across variant periods and for the primary series or booster doses, vaccine effectiveness was similar in those with and those without a disability. These findings highlight the importance of adults with disabilities staying up to date with COVID-19 vaccinations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642729PMC
http://dx.doi.org/10.1093/ofid/ofad474DOI Listing

Publication Analysis

Top Keywords

adults disabilities
12
effectiveness original
8
original monovalent
8
coronavirus disease
8
disease 2019
8
care encounters
8
june 2021-september
8
2021-september 2022
8
monovalent coronavirus
4
2019 vaccines
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!